Pediatrics / Research / Neuromedicine
Neuromedicine
Neuromedicine research in the Department of Pediatrics goes from molecule to cell to organ to organism and from bench to bedside and back again. Molecular studies of neurotrophin and neurotransmitter receptors, neurometabolic substrates, and developmentally relevant proteins underlie the search for biomarkers of and novel therapeutic approaches to developmental disease of the nervous system. Cell biologic studies have uncovered mechanisms of AIDS encephalopathy and developmental origins of Alzheimer disease. Brain and nervous system function studies have allowed development of a severity scale for the neurodegenerative disorder, Batten’s disease, and have enhanced our understanding of movement disorders in children. And clinical drug trials promise to improve the quality of life of patients with AIDS, Tourette syndrome, Batten’s disease, and neuroblastoma.
Investigators
- Heather Adams, Ph.D., Neurology
- Erika Augustine, M.D., Neurology
- Jill Cholette, M.D., Critical Care
- Emma Ciafaloni, M.D., Neurology
- Jake Deines, M.D., Critical Care
- Harris Gelbard, M.D., Ph.D., Center for Neural Development & Disease
- Ronnie Guillet, M.D., Ph.D., Neonatology
- Marc W. Halterman, M.D., Ph.D., Neurology
- J. Peter Harris, M.D., Emeritus, Cardiology
- Susan Hyman, M.D., Developmental and Behavioral Pediatrics
- David Korones, M.D., Hematology and Oncology
- Gary Myers, M.D., Neurology
- Jessica Roesser, M.D., Developmental and Behavioral Pediatrics
- Laura Silverman, Ph.D., Developmental and Behavioral Pediatrics
- Stephen Sulkes, M.D., Developmental and Behavioral Pediatrics